West Tower Group LLC Has $3.86 Million Stake in Perrigo Company plc $PRGO

West Tower Group LLC grew its stake in shares of Perrigo Company plc (NYSE:PRGO) by 45.7% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 173,241 shares of the company’s stock after purchasing an additional 54,327 shares during the period. Perrigo makes up 11.2% of West Tower Group LLC’s investment portfolio, making the stock its largest holding. West Tower Group LLC’s holdings in Perrigo were worth $3,858,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also bought and sold shares of the company. HighTower Advisors LLC increased its stake in shares of Perrigo by 8.9% during the first quarter. HighTower Advisors LLC now owns 14,496 shares of the company’s stock valued at $406,000 after purchasing an additional 1,189 shares in the last quarter. Raymond James Financial Inc. raised its stake in Perrigo by 8.2% during the first quarter. Raymond James Financial Inc. now owns 133,707 shares of the company’s stock valued at $3,749,000 after buying an additional 10,154 shares during the last quarter. Northern Trust Corp boosted its holdings in Perrigo by 2.5% in the first quarter. Northern Trust Corp now owns 1,425,065 shares of the company’s stock worth $39,959,000 after acquiring an additional 35,058 shares in the last quarter. Trexquant Investment LP boosted its holdings in Perrigo by 196.4% in the first quarter. Trexquant Investment LP now owns 139,157 shares of the company’s stock worth $3,902,000 after acquiring an additional 92,215 shares in the last quarter. Finally, State of Wyoming raised its position in shares of Perrigo by 36.0% in the 1st quarter. State of Wyoming now owns 10,879 shares of the company’s stock worth $305,000 after purchasing an additional 2,877 shares during the last quarter. 95.91% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In related news, Director Geoffrey M. Parker acquired 7,500 shares of Perrigo stock in a transaction dated Wednesday, November 12th. The shares were purchased at an average price of $14.18 per share, for a total transaction of $106,350.00. Following the completion of the transaction, the director directly owned 17,375 shares in the company, valued at approximately $246,377.50. This represents a 75.95% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 0.70% of the stock is currently owned by insiders.

Analyst Ratings Changes

A number of equities research analysts have recently commented on the stock. Zacks Research cut shares of Perrigo from a “hold” rating to a “strong sell” rating in a report on Friday, November 7th. Weiss Ratings reissued a “sell (d+)” rating on shares of Perrigo in a report on Monday. Canaccord Genuity Group lowered their price target on Perrigo from $40.00 to $20.00 and set a “buy” rating on the stock in a report on Thursday, November 6th. JPMorgan Chase & Co. reduced their price objective on Perrigo from $20.00 to $18.00 and set a “neutral” rating for the company in a report on Monday, December 15th. Finally, Wall Street Zen cut shares of Perrigo from a “buy” rating to a “hold” rating in a research note on Saturday, November 8th. One analyst has rated the stock with a Buy rating, four have given a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat, Perrigo has a consensus rating of “Reduce” and an average target price of $22.00.

Perrigo Stock Up 0.5%

Shares of PRGO stock opened at $13.83 on Friday. The company has a debt-to-equity ratio of 0.81, a current ratio of 2.51 and a quick ratio of 1.44. Perrigo Company plc has a one year low of $12.17 and a one year high of $30.93. The company’s fifty day moving average price is $15.39 and its 200-day moving average price is $21.31. The company has a market capitalization of $1.90 billion, a price-to-earnings ratio of -36.38 and a beta of 0.39.

Perrigo (NYSE:PRGO) last issued its quarterly earnings results on Wednesday, November 5th. The company reported $0.80 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.75 by $0.05. The business had revenue of $1.04 billion during the quarter, compared to analyst estimates of $1.10 billion. Perrigo had a positive return on equity of 9.16% and a negative net margin of 1.21%.Perrigo’s revenue for the quarter was down 4.1% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.81 EPS. Perrigo has set its FY 2025 guidance at 2.700-2.80 EPS. Sell-side analysts expect that Perrigo Company plc will post 2.56 EPS for the current fiscal year.

Perrigo Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, December 16th. Investors of record on Friday, November 28th were paid a dividend of $0.29 per share. This represents a $1.16 annualized dividend and a yield of 8.4%. The ex-dividend date of this dividend was Friday, November 28th. Perrigo’s dividend payout ratio (DPR) is -305.26%.

Perrigo Profile

Perrigo Company plc is a global healthcare supplier specializing in over-the-counter (OTC) and self-care products, as well as generic prescription pharmaceuticals and active pharmaceutical ingredients. The company develops, manufactures and distributes a broad array of consumer health products, including analgesics, vitamins and supplements, digestive health remedies, topical treatments, and infant formulas. Perrigo’s focus on private-label solutions has made it a leading partner for retailers and pharmacy chains seeking high-quality, value-oriented alternatives to branded medications and health supplements.

Organized across three principal business segments—Consumer Healthcare, Prescription Pharmaceuticals and Active Pharmaceutical Ingredients—Perrigo’s operations span research and development, manufacturing, quality assurance and global distribution.